Actavis Recalls Ramipril Capsules Due to Incorrect Expiration Date Labeling
Actavis is recalling 15,984 bottles of Ramipril Capsules because they were labeled with an incorrect expiration date of 03/18 instead of 09/17.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, and the issue is limited to a documentation/labeling error.
Plain-English summary
Actavis Laboratories, FL, Inc. is recalling 15,984 bottles of Ramipril Capsules, USP, 1.25 mg, 30-count bottles. The product was manufactured by Arrow Pharm (Malta) Ltd. and distributed by Actavis Pharma, Inc. The recall is due to a labeling error where the bottles were marked with an incorrect expiration date of 03/18 rather than the correct date of 09/17.
The affected product is identified by Lot # 1136091A and NDC 16252-570-30. The recall covers distribution nationwide and in Puerto Rico. The FDA has classified this as a Class III recall, indicating that the labeling error is unlikely to cause adverse health consequences.
Consumers who have this product should check the expiration date and lot number on their bottles. If the product matches the recalled lot, they should contact their pharmacist or healthcare provider for guidance on disposal or replacement.
The recalled product
- Product
- Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
- Manufacturer
- Actavis Laboratories, FL, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 15,984
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1136091A
- Incorrectly Labeled Exp: 03/18
Distribution
Related recalls
Same manufacturer · Actavis Laboratories, FL, Inc.
See all →- ModerateActavis Recalls Metformin Hydrochloride Extended-Release Tablets for Dissolution Failure
FDA (Drugs) · 2015-10-21
- LowActavis Recalls Desmopressin Acetate Tablets with Incorrect Imprint
FDA (Drugs) · 2015-08-12
- ModerateActavis Recalls Cartia XT Capsules Due to Aluminum Residue on Exterior
FDA (Drugs) · 2015-04-22
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Split Tablets
FDA (Drugs) · 2014-12-03
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Splitting
FDA (Drugs) · 2014-10-08
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02